Cargando…
Novel non-ATP competitive small molecules targeting the CK2 α/β interface
Increased CK2 levels are prevalent in many cancers. Combined with the critical role CK2 plays in many cell-signaling pathways, this makes it a prime target for down regulation to fight tumour growth. Herein, we report a fragment-based approach to inhibiting the interaction between CK2α and CK2β at t...
Autores principales: | Brear, Paul, North, Andrew, Iegre, Jessica, Hadje Georgiou, Kathy, Lubin, Alexandra, Carro, Laura, Green, William, Sore, Hannah F., Hyvönen, Marko, Spring, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562204/ https://www.ncbi.nlm.nih.gov/pubmed/29759799 http://dx.doi.org/10.1016/j.bmc.2018.05.011 |
Ejemplares similares
-
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066
por: De Fusco, Claudia, et al.
Publicado: (2017) -
Second-generation CK2α inhibitors targeting the αD pocket
por: Iegre, Jessica, et al.
Publicado: (2018) -
Specific inhibition of CK2α from an anchor outside the active site
por: Brear, Paul, et al.
Publicado: (2016) -
Development of small cyclic peptides targeting the CK2α/β interface
por: Atkinson, Eleanor L., et al.
Publicado: (2022) -
Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study
por: Atkinson, Eleanor L., et al.
Publicado: (2021)